246 related articles for article (PubMed ID: 22275832)
1. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.
Xie F; Yao N; Qin Y; Zhang Q; Chen H; Yuan M; Tang J; Li X; Fan W; Zhang Q; Wu Y; Hai L; He Q
Int J Nanomedicine; 2012; 7():163-75. PubMed ID: 22275832
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes.
Qin Y; Fan W; Chen H; Yao N; Tang W; Tang J; Yuan W; Kuai R; Zhang Z; Wu Y; He Q
J Drug Target; 2010 Aug; 18(7):536-49. PubMed ID: 20132091
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z
Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613
[No Abstract] [Full Text] [Related]
5. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
Qin Y; Chen H; Yuan W; Kuai R; Zhang Q; Xie F; Zhang L; Zhang Z; Liu J; He Q
Int J Pharm; 2011 Oct; 419(1-2):85-95. PubMed ID: 21807083
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y
Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913
[TBL] [Abstract][Full Text] [Related]
7. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.
Wang Z; Zhao Y; Jiang Y; Lv W; Wu L; Wang B; Lv L; Xu Q; Xin H
Sci Rep; 2015 Jul; 5():12651. PubMed ID: 26219474
[TBL] [Abstract][Full Text] [Related]
9. Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery.
Wu Y; Zhang B; Kebebe D; Guo L; Guo H; Li N; Pi J; Qi D; Guo P; Liu Z
Pharm Dev Technol; 2019 Oct; 24(8):982-991. PubMed ID: 31107131
[TBL] [Abstract][Full Text] [Related]
10. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
Wei M; Xu Y; Zou Q; Tu L; Tang C; Xu T; Deng L; Wu C
Eur J Pharm Sci; 2012 Jun; 46(3):131-41. PubMed ID: 22369856
[TBL] [Abstract][Full Text] [Related]
12. Targeted Delivery of Macrophage Membrane Biomimetic Liposomes Through Intranasal Administration for Treatment of Ischemic Stroke.
Liu T; Zhang M; Zhang J; Kang N; Zheng L; Ding Z
Int J Nanomedicine; 2024; 19():6177-6199. PubMed ID: 38911498
[TBL] [Abstract][Full Text] [Related]
13. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
14. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
[TBL] [Abstract][Full Text] [Related]
16. The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain.
Zhang X; Xie Y; Jin Y; Hou X; Ye L; Lou J
Drug Deliv; 2004; 11(5):301-9. PubMed ID: 15742555
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation.
Li J; Cheng X; Chen Y; He W; Ni L; Xiong P; Wei M
Int J Pharm; 2016 Oct; 512(1):262-272. PubMed ID: 27545748
[TBL] [Abstract][Full Text] [Related]
18. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
19. Liposomes modified with P-aminophenyl-α-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice.
Hao ZF; Cui YX; Li MH; Du D; Liu MF; Tao HQ; Li S; Cao FY; Chen YL; Lei XH; Wang L; Zhu DL; Peng HS; Jiang CL
Eur J Pharm Biopharm; 2013 Aug; 84(3):505-16. PubMed ID: 23376242
[TBL] [Abstract][Full Text] [Related]
20. The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.
Yu Y; Jiang X; Gong S; Feng L; Zhong Y; Pang Z
Nanoscale; 2014 Mar; 6(6):3250-8. PubMed ID: 24503971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
